articleAnnals of OncologyNov 2, 2006Closed access

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

National Cancer Center · The University of Tokyo · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

637
total citations
FWCI
25.97
Percentile
100%
References
31
Citations per year

Authors

10

Topics & keywords

Keywords
  • Medicine
  • Gemcitabine
  • Carboplatin
  • Irinotecan
  • Cisplatin
  • Vinorelbine
  • Lung cancer
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding